The right-to-die movement advocating the passage of state legislation to allow medical aid in dying is gaining momentum.
Debunking some of the misconceptions about the world’s leading cause of blindness could help many people get the treatment they need.
Potentially curative gene therapy is in the works for hemophilia.
Pricing of drugs is far more complex than the big, bad pharma price-gouging narrative.
For the many different types of diabetes, there are no cures yet, but a host of successful treatments available, with myriad more being studied.
Private and public healthcare challenges grow as an aging population grapples with the ramifications of increasing numbers of HIV-positive senior citizens.
Hereditary angioedema is a rare genetic disease for which replacement therapy provides safe and highly effective treatment.
Researchers are taking a closer look at intravenous immune globulin for its potential to stop the progression of multiple complex conditions from lupus to multiple sclerosis.
The best defense against influenza remains annual immunization against emergent influenza strains.
This disease is caused by multiple factors, most prominently other health conditions. And, while it is incurable, symptoms can be eased with treatment.
Central pain syndrome affects several million people worldwide, yet this condition wasn’t fully understood until recently, and there are still many challenges concerning diagnosis and treatment.
E-cigarettes have gained significant popularity in recent years, rivaling the use of traditional cigarettes, due to a number of myths surrounding their presumed safety and purported benefits.
